Results In-Line with Expectations Product Sales Backlog Ended Quarter at $648 million, Up Over 130% Sequentially Over $200 million in Contract Operation […]
– Expansion of gene therapy collaboration with University of Pennsylvania’s Gene Therapy Program extends collaboration by three additional years and […]
CAMBRIDGE, Mass., May 11, 2020 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives […]